CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS

摘要

Compounds of Formula (I) are disclosed which inhibit hepatitis C NS5B RNA-dependent RNA polymerase and are useful for treating hepatitis C. Compositions and methods of using these compounds are also disclosed.